DARK SECRETS: Arcturus therapeutics | Vintage Vibes

Arcturus Therapeutics Highlights mRNA Pipeline, CF Data and Vaccine Expansion at Jefferies

Arcturus Therapeutics (NASDAQ:ARCT) President and CEO Joseph Payne outlined the company’s messenger RNA programs, vaccine approvals and upcoming clinical milestones during a presentation at the Jefferies Global Healthcare Conference in New York. Payne described Arcturus as a “next generation messen

MarketBeat · Jun 5

Cathie Wood Adds 48K Shares to This Under-the-Radar Growth Play

Wood trimmed stakes in Nvidia, Meta, and Tesla; instead, she added this speculative biotech play.

Barchart · Mar 31

1 Under-$10 Stock Set to Surge as Much as 963% in 2026

The high price estimate for Arcturus suggests the stock can rally as high as 963%. Is it a far-fetched target?

Barchart · Jan 10